Pulmonary langerhans cell histiocytosis secondary to Marijuana use: a case report and systematic review of the literature.

IF 2.8 3区 医学 Q2 RESPIRATORY SYSTEM BMC Pulmonary Medicine Pub Date : 2025-01-27 DOI:10.1186/s12890-025-03513-3
Ibrahim Zahid, Aruba Sohail, Roohan Tahir, Matthew Belardo, Brandon Hooks
{"title":"Pulmonary langerhans cell histiocytosis secondary to Marijuana use: a case report and systematic review of the literature.","authors":"Ibrahim Zahid, Aruba Sohail, Roohan Tahir, Matthew Belardo, Brandon Hooks","doi":"10.1186/s12890-025-03513-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pulmonary Langerhans Cell Histiocytosis (PLCH) is a rare interstitial lung disease primarily affecting young to middle-aged smokers. While traditionally linked to tobacco use, there is growing evidence that cannabis use may contribute to PLCH.</p><p><strong>Methods: </strong>We present a case of a 52-year-old male with PLCH associated with heavy cannabis use. Diagnostic evaluations included CT scan of the chest and histopathological examination of a lung biopsy. In addition, a comprehensive review of the literature was conducted to identify and analyze similar cases of PLCH linked to cannabis use. Databases searched included PubMed and Google Scholar, following PRISMA guidelines.</p><p><strong>Results: </strong>The patient presented with dyspnea, cough and unintentional weight loss. The patient had a 20-year history of smoking approximately ten cannabis blunts per day. Despite normal initial chest X-ray findings, a CT scan of his chest revealed upper lobe predominant cystic changes and emphysema. Histopathology from a transbronchial biopsy confirmed the presence of Langerhans cells, consistent with PLCH. Literature review identified five additional case reports of PLCH associated with cannabis use, involving patients aged 16 to 59 years, with a mean age of 35.8 years. Common clinical presentations included cough, dyspnea, and chest pain, with radiographic findings of nodules and cysts. Treatment was primarily targeted towards smoking cessation, which led to clinical improvement in all cases.</p><p><strong>Conclusions: </strong>This case underscores the potential association between heavy cannabis use and the development of PLCH. With the increasing prevalence of cannabis consumption, it is essential to recognize cannabis as a possible risk factor for PLCH. Further research is needed to understand the pathophysiological mechanisms underlying cannabis-related PLCH. As cannabis use becomes more prevalent with changing legislation, understanding its impact on lung health and potential role in diseases like PLCH is increasingly important.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"44"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11773874/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pulmonary Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12890-025-03513-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pulmonary Langerhans Cell Histiocytosis (PLCH) is a rare interstitial lung disease primarily affecting young to middle-aged smokers. While traditionally linked to tobacco use, there is growing evidence that cannabis use may contribute to PLCH.

Methods: We present a case of a 52-year-old male with PLCH associated with heavy cannabis use. Diagnostic evaluations included CT scan of the chest and histopathological examination of a lung biopsy. In addition, a comprehensive review of the literature was conducted to identify and analyze similar cases of PLCH linked to cannabis use. Databases searched included PubMed and Google Scholar, following PRISMA guidelines.

Results: The patient presented with dyspnea, cough and unintentional weight loss. The patient had a 20-year history of smoking approximately ten cannabis blunts per day. Despite normal initial chest X-ray findings, a CT scan of his chest revealed upper lobe predominant cystic changes and emphysema. Histopathology from a transbronchial biopsy confirmed the presence of Langerhans cells, consistent with PLCH. Literature review identified five additional case reports of PLCH associated with cannabis use, involving patients aged 16 to 59 years, with a mean age of 35.8 years. Common clinical presentations included cough, dyspnea, and chest pain, with radiographic findings of nodules and cysts. Treatment was primarily targeted towards smoking cessation, which led to clinical improvement in all cases.

Conclusions: This case underscores the potential association between heavy cannabis use and the development of PLCH. With the increasing prevalence of cannabis consumption, it is essential to recognize cannabis as a possible risk factor for PLCH. Further research is needed to understand the pathophysiological mechanisms underlying cannabis-related PLCH. As cannabis use becomes more prevalent with changing legislation, understanding its impact on lung health and potential role in diseases like PLCH is increasingly important.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
继发于大麻使用的肺朗格汉斯细胞组织细胞增生症:病例报告和文献系统回顾。
背景:肺朗格汉斯细胞组织细胞增多症(PLCH)是一种罕见的间质性肺疾病,主要影响中青年吸烟者。虽然传统上与烟草使用有关,但越来越多的证据表明,大麻使用可能会导致PLCH。方法:我们提出了一例52岁男性PLCH与大量使用大麻。诊断评估包括胸部CT扫描和肺活检的组织病理学检查。此外,还对文献进行了全面审查,以确定和分析与大麻使用有关的PLCH的类似病例。检索的数据库包括PubMed和谷歌Scholar,遵循PRISMA指南。结果:患者表现为呼吸困难、咳嗽、体重减轻。患者有20年的吸食史,每天吸食约10支大麻。尽管最初的胸部x线检查结果正常,但胸部CT扫描显示上肺叶主要的囊性改变和肺气肿。经支气管活检组织病理学证实朗格汉斯细胞的存在,与PLCH一致。文献回顾确定了另外5例与大麻使用相关的PLCH病例报告,涉及患者年龄在16至59岁之间,平均年龄为35.8岁。常见的临床表现包括咳嗽、呼吸困难和胸痛,影像学表现为结节和囊肿。治疗主要针对戒烟,这导致所有病例的临床改善。结论:该病例强调了重度大麻使用与PLCH发展之间的潜在关联。随着大麻消费的日益流行,必须认识到大麻是PLCH的一个可能的危险因素。需要进一步研究大麻相关PLCH的病理生理机制。随着立法的变化,大麻的使用变得越来越普遍,了解其对肺部健康的影响以及在PLCH等疾病中的潜在作用变得越来越重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Pulmonary Medicine
BMC Pulmonary Medicine RESPIRATORY SYSTEM-
CiteScore
4.40
自引率
3.20%
发文量
423
审稿时长
6-12 weeks
期刊介绍: BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
期刊最新文献
Ultrasound-guided tourniquet pressure setting enhances hemodynamic stability and pulmonary function by attenuating oxidative stress in patients undergoing lower-limb surgery: a randomised trial. Prognostic significance of CEP55 expression in non-small cell lung cancer: a systematic review and meta-analysis. Efficacy of single-inhaler triple therapies for chronic obstructive pulmonary disease: a systematic review and network meta-analysis. Determinants of high chronic obstructive pulmonary disease assessment test scores according to airflow limitation severity: a three-year prospective study. Regional differences of lung parenchyma attenuation after contrast administration in quantitative dual energy chest CT.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1